| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |